VivoSim Wants to Fix the Worst Odds in Medicine: An 8 Percent Success Rate
Most new drugs never make it to a pharmacy shelf. According to industry-wide data tracked by pharmaceutical trade groups, roughly 92 percent of drugs that enter clinical trials fail before reaching approval, a number that has actually gotten worse over the last decade, dropping from a 9 percent success rate to about 8 percent. VivoSim, a San Diego biotech company based in the Sorrento Valley research corridor, is building lab-grown human tissue models designed to catch failures earlier, before a drug ever reaches a human trial. What VivoSim Actually Builds VivoSim’s core technology is a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.